Vitura is proud to showcase a diverse portfolio of brands across the digital health, emerging therapeutics and medicinal cannabis space. Each brand uniquely contributes to developing the healthcare ecosystem – educating stakeholders, clinicians and patients alike and providing new services and solutions to those who need them most.
Our Brands
An online platform that delivers prescribing, dispensing and medication management solutions for medicinal cannabis, Canview enables registered health professionals to browse, prescribe and order medicines in one streamlined, compliant and free-to-use platform. Canview simplifies the prescribing and ordering process for both doctors and pharmacists. In addition, the platform equips patients to access the widest range of available products and easily manage their ongoing treatment journey.
Founded in 2015 and acquired by Vitura Health in October 2023, Doctors on Demand is a premier provider of on-demand virtual healthcare services across Australia. With a core focus on fostering meaningful connections between healthcare practitioners and patients, Doctors on Demand is dedicated to delivering healthcare solutions that grant individuals the freedom to determine who, what, when and how they connect with their healthcare providers.
Cortexa, an Australian company based in Melbourne, is one of the only companies in the world able to supply validated psychedelics ready for patient use. Since 1 July 2023, specific psychedelics can be prescribed by approved authorised psychiatrists for the treatment of certain mental health conditions. Based on these changes, Cortexa will be leading in the supply of support and product to clinicians, and clinical research sites throughout Australia.
One of the first of its kind in Australia, CDA Clinics has been providing medicinal cannabis consultations and prescription services to eligible Australian patients since 2018. The CDA Clinics team is comprised of highly experienced and widely trusted doctors who deliver individualised, tailored assessments for each patient’s condition. CDA’s qualified doctors, nurses, and support team are renowned for their comprehensive knowledge in the medicinal cannabis field and are well regarded for their compassionate and caring approach to patient treatment.
Established in 2019, Cannadoc is a medicinal cannabis clinic that offers nation-wide telehealth consultations. The Cannadoc team are dedicated to improving quality of life for their patients and lead the way in the management of complex, chronic conditions through doctor-only consults and free nurse support.
Established in 2016, Burleigh Heads Cannabis (BHC) is a pioneer in the Australian medicinal cannabis industry and one of the first companies in Australia to receive its importation and wholesale license for medicinal cannabis. BHC is now one of Australia’s largest and most well-known medicinal cannabis distributors that partners with domestic and international suppliers to provide a full-service offering - from initial market entry and exposure to a growth sales channel backed by its integrated technology solutions and extensive distribution network. BHC leverages its established national footprint and logistics partners to supply medicinal cannabis products to thousands of pharmacies and doctors via its platform, Canview – while leading the way in industry compliance.
Launching to the market in 2020, Adaya’s plant-based range of medication includes a portfolio of hybrid formulations in medium chain triglyceride oil and Australian-cultivated whole flower products. While quality is paramount, the brand also places importance on affordability, further strengthening their goal of sustainable patient access. All items in Adaya’s range are manufactured in compliance with AU-GMP pharmaceutical quality and safety standards.